The Benefit of Benralizumab Monoclonal Antibody Treatment for Severe Eosinophilic Asthma in a Case Series (Pulmonology Clinic Târgu Mureș, Romania)
, , , , , , y
14 oct 2021
Acerca de este artículo
Publicado en línea: 14 oct 2021
Páginas: 157 - 161
Recibido: 04 sept 2021
Aceptado: 11 sept 2021
DOI: https://doi.org/10.2478/jim-2021-0030
Palabras clave
© 2021 Nimród László et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
László, Nimród
Clinic of Pneumology, Emergency County Clinical HospitalTârgu Mureș, Romania
Sárközy, Hédy Katalin
“George Emil Palade” University of Medicine, Pharmacy, Science and TechnologyTârgu Mureș, Romania
Man, Cristina Alexandra
Clinic of Pneumology, Emergency County Clinical HospitalTârgu Mureș, Romania
Ianoși, Edith Simona
“George Emil Palade” University of Medicine, Pharmacy, Science and TechnologyTârgu Mureș, Romania
Mátyás, Botond
“George Emil Palade” University of Medicine, Pharmacy, Science and TechnologyTârgu Mureș, Romania
Ciurba, Bianca Emilia
Clinic of Pneumology, Emergency County Clinical HospitalTârgu Mureș, Romania
Mărginean, Corina
Clinic of Pneumology, Emergency County Clinical HospitalTârgu Mureș, Romania
Jimborean, Gabriela
“George Emil Palade” University of Medicine, Pharmacy, Science and TechnologyTârgu Mureș, Romania